IRIS UniCatt

Bentivoglio, Anna Rita
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.964
EU - Europa 9.188
AS - Asia 8.077
SA - Sud America 1.779
AF - Africa 238
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 15
Totale 29.292
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.682
SG - Singapore 3.646
DE - Germania 2.941
CN - Cina 2.293
BR - Brasile 1.462
SE - Svezia 1.364
IT - Italia 1.049
UA - Ucraina 865
FR - Francia 766
GB - Regno Unito 495
IE - Irlanda 480
VN - Vietnam 389
IN - India 353
FI - Finlandia 317
ID - Indonesia 297
RU - Federazione Russa 281
HK - Hong Kong 226
TR - Turchia 190
AR - Argentina 133
CA - Canada 127
PL - Polonia 121
NL - Olanda 107
BD - Bangladesh 102
JP - Giappone 98
MX - Messico 98
IQ - Iraq 92
ES - Italia 82
BE - Belgio 75
CI - Costa d'Avorio 70
AT - Austria 67
KR - Corea 60
ZA - Sudafrica 58
EC - Ecuador 49
IR - Iran 44
PK - Pakistan 43
SA - Arabia Saudita 37
UZ - Uzbekistan 30
VE - Venezuela 30
AU - Australia 27
CO - Colombia 27
IL - Israele 24
CZ - Repubblica Ceca 23
CH - Svizzera 22
LT - Lituania 22
KE - Kenya 20
MA - Marocco 20
CL - Cile 19
PY - Paraguay 19
BO - Bolivia 18
JO - Giordania 18
AE - Emirati Arabi Uniti 16
AZ - Azerbaigian 16
RO - Romania 16
KZ - Kazakistan 14
BG - Bulgaria 13
TN - Tunisia 13
EG - Egitto 12
EU - Europa 12
DZ - Algeria 11
PA - Panama 11
UY - Uruguay 11
HU - Ungheria 10
PE - Perù 10
AL - Albania 9
CR - Costa Rica 9
NP - Nepal 9
DK - Danimarca 8
OM - Oman 8
PS - Palestinian Territory 8
SN - Senegal 8
EE - Estonia 7
ET - Etiopia 7
GR - Grecia 7
LB - Libano 7
MY - Malesia 7
PH - Filippine 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
HN - Honduras 6
LU - Lussemburgo 6
MD - Moldavia 6
NI - Nicaragua 6
AM - Armenia 4
BH - Bahrain 4
GA - Gabon 4
JM - Giamaica 4
KG - Kirghizistan 4
KW - Kuwait 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
SY - Repubblica araba siriana 4
TW - Taiwan 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
KH - Cambogia 3
MG - Madagascar 3
MK - Macedonia 3
NG - Nigeria 3
QA - Qatar 3
Totale 29.249
Salva come PNG Salva come JPEG
Città #
Singapore 1.585
Chandler 1.551
Ashburn 1.093
Dublin 473
Jacksonville 455
Beijing 423
San Mateo 369
Nanjing 294
Jakarta 279
Ann Arbor 275
New York 270
Wilmington 244
Hefei 243
Munich 223
Los Angeles 218
Rome 195
Boston 194
Dearborn 187
Milan 164
Dallas 159
Woodbridge 153
Houston 147
Lawrence 141
Nürnberg 137
Moscow 135
Cattolica 126
São Paulo 121
Ho Chi Minh City 118
Izmir 117
Marseille 116
Chicago 115
Frankfurt am Main 115
Seattle 112
Hanoi 107
Hong Kong 103
Redwood City 102
Lancaster 100
Boardman 96
Princeton 95
Warsaw 91
Redmond 89
The Dalles 89
Nanchang 88
Helsinki 87
Fairfield 82
Shenyang 74
Abidjan 70
Brussels 68
Norwalk 65
London 64
Buffalo 63
Kent 62
Tokyo 62
Hebei 59
Jiaxing 56
Mountain View 55
Pune 54
Hangzhou 52
Tianjin 52
Seoul 51
University Park 51
Rio de Janeiro 50
Brooklyn 46
Bremen 45
Changsha 45
Kunming 43
Nuremberg 42
Santa Clara 40
Leawood 38
Shanghai 38
Brasília 37
Montreal 36
Vienna 36
Chennai 35
Denver 35
Johannesburg 35
Phoenix 34
Guangzhou 33
Orem 32
Trieste 32
Zhengzhou 32
Baghdad 31
Belo Horizonte 31
Toronto 31
Stockholm 30
Fremont 29
North Bergen 29
Turku 29
Lappeenranta 28
Mexico City 28
Augusta 27
Düsseldorf 26
Tashkent 26
Washington 26
Amsterdam 25
Ankara 24
Curitiba 24
Dhaka 24
Simi Valley 24
Cambridge 23
Totale 13.913
Salva come PNG Salva come JPEG
Nome #
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 354
The role of small intestinal bacterial overgrowth in Parkinson's disease 230
Heart Rate Variability during wake and sleep in Huntington's Disease patients. An observational, cross-sectional, cohort study 220
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
Difference in striatal dopamine transporter availability and psychiatric symptoms in Parkinson's disease subtypes: 123I-FP-CIT SPECT results 198
Beyond the CAG triplet number: exploring potential predictors of delayed age of onset in Huntington's disease 187
Association of depressive symptoms with circadian blood pressure alterations in Parkinson's disease 187
Patient's Loss of Empathy Is Associated With Caregiver Burden 187
Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants 183
Unilateral Extradural Motor Cortex Stimulation is Safe and Improves Parkinson's Disease at 1 Year 182
Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease 176
Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease 175
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report. 175
Mutation screening of the DYT6/THAP1 gene in Italy 173
Striatal dopamine transporter (DAT) availability and affective symptoms in movement disorders: a 123I-FP-CIT SPECT study. 172
Assessment of neurological manifestations in hospitalized patients with COVID-19 172
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study 171
The left parietal lobe plays a role in the pathogenesis of blepharospasm? 168
Botulinum toxin A versus B in sialorrhea: A prospective, randomized, double-blind, crossover pilot study in patients with amyotrophic lateral sclerosis or Parkinson's disease. 166
Olfactory dysfunction in Parkinsonism caused by PINK1 mutations 163
Rehabilitation of hypomimia in Parkinson's disease: a feasibility study of two different approaches 163
PUNDING IN PARKINSON'S DISEASE: THE IMPACT OF PATIANT'S AWARENESS ON DIAGNOSIS 161
Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease 161
Extradural motor cortex stimulation improves gait, speech, and language in a patient with pure akinesia 161
Correlations Between Striatal Dopamine Transporter (DAT) Availability and Psychiatric Symptoms in Movement Disorders: A 123I-FP-CIT SPECT Study. 159
Emotional Awareness, Relationship Quality, and Satisfaction in Patients With Parkinson's Disease and Their Spousal Caregivers 158
Dopaminergic agents and nutritional status in Parkinson's disease 155
Age at onset and symptom spread in primary adult-onset blepharospasm and cervical dystonia 154
Atrofia multisistemica: correlazioni tra caratteristiche cliniche, prove di reflettività cardiovascolare e reperti di risonanza magnetica 152
The progression of non-motor symptoms in Parkinson's disease and their contribution to motor disability and quality of life 151
Phenotypic characterisation of DYT13 primary torsion distonia. 148
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 148
Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment 147
Prevalence of Impulsive-Compulsive Symptoms in Elderly Parkinson's Disease Patients: A Case-Control Study 147
Movement disorders in multiple sclerosis: Causal or coincidental association? 145
Novel mutations in SPG11 cause hereditary spastic paraplegia associated with early-onset levodopa responsive parkinsonism 144
Botulinum toxin in the treatment of outlet obstruction constipation due to puborectalis syndrome 143
Reliability of Clinical Diagnosis of Dystonia 143
Fifteen-year experience in treating blepharospasm with Botox or Dysport: same toxin, two drugs 142
Epidemiological, Clinical, and Molecular Study of a Cohort of Italian Parkinson Disease Patients: Association with Glutathione-S-Transferase and DNA Repair Gene Polymorphisms 142
Depression Symptoms and Clinical Subtypes in Parkinson's Disease Patients: a I-123-FP-CIT SPECT Study 142
New olfactometric findings in Parkinson's disease 142
Effects of COVID-19 Lockdown on Movement Disorders Patients With Deep Brain Stimulation: A Multicenter Survey 142
Prevalence of spinocellulart ataxia type 2 mutation among ittalian Parkinsonian patients 141
Clinical presentation and progression of sporadic and familial primary torsion dystonia in Italy. 140
Phenotypic variability of PINK1 expression: 12 Years' clinical follow-up of two Italian families 140
Relief by botulinum toxin of voiding dysfunction due to benign prostatic hyperplasia. Results of a randomised, placebo-controlled study. 139
Dystonia gravidarum: a new case with a long follow-up 138
Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study 138
Clinical and genetic characteristics of late-onset Huntington's disease 138
Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview 137
Use of ACE-inhibitors and falls in patients with Parkinson's disease 137
Mitochondrial Signatures in Circulating Extracellular Vesicles of Older Adults with Parkinson's Disease: Results from the EXosomes in PArkiNson's Disease (EXPAND) Study 137
Extradural Motor Cortex Stimulation in Parkinson's Disease: Long-Term Clinical Outcome. 136
Impulsive-compulsive behaviors in parkin-associated Parkinson disease 135
Nigro-striatal involvement in primary progressive freezing gait: insights into a heterogeneous pathogenesis 133
Aristotle's illusion reveals interdigit functional somatosensory alterations in focal hand dystonia 132
High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease 132
Cardiovascular autonomic nervous system evaluation in Parkinson disease and multiple system atrophy 132
Transcranial magnetic stimulation predicts functional recovery after botulinum toxin treatment in stroke patients 132
Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature 132
Extradural Motor Cortex Stimulation might improve episodic and working memory in patients with Parkinson’s disease 131
Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report 130
Analysis of blink rate in patients with blepharospasm 130
Working on asymmetry in Parkinson's disease: randomized, controlled pilot study 130
Measuring gait quality in Parkinson’s disease through real-time gait phase recognition 129
Aceruloplasminemia: a novel mutation in a family with marked phenotypic variability 128
Early DEtection of wEaring off in Parkinson disease: the DEEP study 128
Neuroacanthocytosis Syndromes in an Italian Cohort: Clinical Spectrum, High Genetic Variability and Muscle Involvement 128
Punding and computer addiction in Parkinson's disease 127
Blepharospasm with non-satisfactory response to treatment: Our experience with IncobotulinumtoxinA 127
Non-DYT1 early onset primary torsion dystonia: comparison with DYT1 phenotype and review of the literature 126
Liquid melevodopa versus standard levodopa in patients with Parkinson disease and small intestinal bacterial overgrowth 126
Parkinson’s disease and virtual reality rehabilitation: cognitive reserve influences the walking and balance outcome 126
A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. 125
Botulinum toxin B ultrasound-guided injections for sialorrhea in amyotrophic lateral sclerosis and Parkinson's disease. 125
GPi-DBS in Huntington's disease: results on motor function and cognition in a 72-year-old case 124
Tremor in primary adult-onset dystonia: prevalence and associated clinical features 124
Cardiac autonomic nervous system evaluation in Parkinson disease and multisystem atrophy 123
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up 123
Association of metabolic syndrome with falls in patients with Parkinson's disease 123
Clinical differences between botulinum neurotoxin type A and B 123
Treatment of outlet obstruction constipation in Parkinson's disease with botulinum neurotoxin A. 122
Disappearance of antiphospholipid antibodies syndrome after Helicobacter pylori eradication 122
Impact of disease duration and cardiovascular dysautonomia on hypertension in Parkinson's disease 122
Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm 119
PINK1 mutations are associated with sporadic early-onset parkinsonism. 118
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 117
Impulsive compulsive behaviours in Parkinson's disease: patients' versus caregivers' perceptions 117
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 116
Abnormal gating of somatosensory inputs in essential tremor. 116
Levodopa effect on electromyographic activation patterns of tibialis anterior muscle during walking in Parkinson's disease 116
Rapid Eye Movement Sleep Behavior Disorder: A Window on the Emotional World of Parkinson Disease, A Window on Dreaming 116
Polysomnographic Findings and Clinical Correlates in Huntington Disease. A Cross-sectional Cohort Study. 116
Prevalence of Obsessive-Compulsive Symptoms in Elderly Parkinson Disease Patients: A Case-Control Study 114
Cocaine addiction: from habits to stereotypical-repetitive behaviors and punding 114
Tourettism in multiple sclerosis: a case report 114
Reduced facial expressiveness in Parkinson's disease: A pure motor disorder? 114
DJ-1 modulates mitochondrial response to oxidative stress: clues from a novel diagnosis of PARK7 114
The long-term effect of tetrabenazine in the management of Huntington disease 113
Totale 14.493
Salva come PNG Salva come JPEG
Categoria #
all - tutte 129.999
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 129.999
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.136 0 0 0 0 0 78 229 55 250 116 369 39
2021/20222.131 188 215 58 116 110 67 38 313 82 153 327 464
2022/20234.483 523 589 355 602 337 528 238 351 645 90 161 64
2023/20242.319 86 663 77 159 90 307 145 151 34 67 252 288
2024/20254.977 104 171 409 152 383 199 207 254 762 431 1.057 848
2025/20267.264 1.941 420 840 1.412 2.134 517 0 0 0 0 0 0
Totale 29.637